Barclays’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,969
| Closed | -$14K | – | 4034 |
|
|
2021
Q3 | $14K | Sell |
6,969
-42,870
| -86% | -$86.1K | ﹤0.01% | 3711 |
|
|
2021
Q2 | $148K | Buy |
49,839
+13,032
| +35% | +$38.7K | ﹤0.01% | 3001 |
|
|
2021
Q1 | $102K | Buy |
36,807
+22,595
| +159% | +$62.6K | ﹤0.01% | 3370 |
|
|
2020
Q4 | $34K | Sell |
14,212
-2,266
| -14% | -$5.42K | ﹤0.01% | 3300 |
|
|
2020
Q3 | $35K | Sell |
16,478
-3,319
| -17% | -$7.05K | ﹤0.01% | 3397 |
|
|
2020
Q2 | $74K | Buy |
19,797
+7,796
| +65% | +$29.1K | ﹤0.01% | 3246 |
|
|
2020
Q1 | $23K | Sell |
12,001
-25,076
| -68% | -$48.1K | ﹤0.01% | 3360 |
|
|
2019
Q4 | $77K | Buy |
37,077
+17,718
| +92% | +$36.8K | ﹤0.01% | 3509 |
|
|
2019
Q3 | $46K | Sell |
19,359
-15,160
| -44% | -$36K | ﹤0.01% | 3704 |
|
|
2019
Q2 | $108K | Buy |
34,519
+10,413
| +43% | +$32.6K | ﹤0.01% | 3552 |
|
|
2019
Q1 | $120K | Buy |
24,106
+23,900
| +11,602% | +$119K | ﹤0.01% | 3254 |
|
|
2018
Q4 | $1K | Sell |
206
-72,034
| -100% | -$350K | ﹤0.01% | 4050 |
|
|
2018
Q3 | $350K | Buy |
72,240
+16,469
| +30% | +$79.8K | ﹤0.01% | 2809 |
|
|
2018
Q2 | $335K | Buy |
55,771
+34,662
| +164% | +$208K | ﹤0.01% | 2490 |
|
|
2018
Q1 | $188K | Buy |
21,109
+17,125
| +430% | +$153K | ﹤0.01% | 2865 |
|
|
2017
Q4 | $28K | Buy |
3,984
+3,446
| +641% | +$24.2K | ﹤0.01% | 3592 |
|
|
2017
Q3 | $4K | Buy |
538
+521
| +3,065% | +$3.87K | ﹤0.01% | 3752 |
|
|
2017
Q2 | $0 | Sell |
17
-15,297
| -100% | – | ﹤0.01% | 4181 |
|
|
2017
Q1 | $73K | Buy |
+15,314
| New | +$73K | ﹤0.01% | 2965 |
|